Evelyne Friedel, Tasmina Goraya and Mathias Kuhn discuss the CJEU's first ruling on the scope of the definition of 'medical device' in the Medical Devices Directive as it applies to standalone software.
Daniel Tietjen explains the coalition proposal in Germany that local pharmacies should be strengthened by banning the mail-order of prescription-only medicinal products.
Bram Nijhof discusses how the issue of high prices for medicines is at the top of the Dutch Authority for Consumer and Market's priority list in the coming two years.
From behind the scenes, Matthew Royle reviews the arguments heard by the CJEU in the latest SPC referral from Arnold J in Teva and others v Gilead, C-121/17.
Andrew Payne reports on the UKIPO consultation paper on the implementation of Directive 2016/943/EU concerning trade secrets into UK law.
Tasmina Goraya discusses a UK government review considering how the UK health system responds to reports from patients about side effects from three NHS treatments.
Matthew Royle considers the latest statement from the UK Government on Brexit and medicines.
Andrew Payne reviews Wellcome's report on the possible structure of a new UK-EU research partnership following the UK's departure from the EU.